The Atlantic magazine features Dr. Roberta Diaz Brinton, her research journey, and why today’s Alzheimer’s research is moving from a one-size-fits-all approach to more personalized medicine strategies. The University of Arizona Center for Innovation in Brain Scienis working to develop the first regenerative therapeutic for a disease that is expected to affect more than 7.7 million people by 2030.
The Atlantic:Rethink – Alzheimer’s is More Complicated Than We Thought